Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
about
Targeting aspartate aminotransferase in breast cancerImaging in breast cancer: Single-photon computed tomography and positron-emission tomographyPositron Emission Tomography in Breast CancerAdvances in molecular imaging for breast cancer detection and characterizationOncometabolites: tailoring our genesExpression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer.(18)F-FDG PET/CT Findings in a Breast Cancer Patient with Concomitant Tuberculous Axillary Lymphadenitis.Correlation of Prognostic Factors of Invasive Lobular Carcinoma with ADC Value of DWI and SUVMax of FDG-PETEarly metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysisThe Structural Basis of Action of Vanadyl (VO(2+)) Chelates in Cells.Physical effects of mechanical design parameters on photon sensitivity and spatial resolution performance of a breast-dedicated PET systemDecoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study.Regulation of the Warburg effect in early-passage breast cancer cells.PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.Molecular Imaging in Breast Cancer - Potential Future Aspects.The potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression.Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.Oncogene pathway activation in mammary tumors dictates FDG-PET uptakeUtility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancersEvaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesSynthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-AnalysisAdvanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.A beta-camera integrated with a microfluidic chip for radioassays based on real-time imaging of glycolysis in small cell populations.Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancerAnti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cellsPrognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.Comparison of diffuse optical tomography of human breast with whole-body and breast-only positron emission tomography.Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.Study of the performance of a novel 1 mm resolution dual-panel PET camera design dedicated to breast cancer imaging using Monte Carlo simulation.
P2860
Q22000773-EE0B11D1-3D57-4335-9DE2-6ABE001DC205Q24810786-2FF6C5DD-A135-40F6-98A4-4289A9EF5D19Q26768486-FF32A3CA-EC92-4147-B7A4-1151507CE6FAQ27000462-859080B6-B167-4A24-8300-617F7B661CD6Q28085392-EA0A64F0-5A8E-43A6-B8B8-96C5709C0A46Q33395114-8520096C-22CC-4717-A9CF-4C291EE562B1Q33669828-68FCBFF1-7363-4375-9B46-265D30F734CBQ33669878-BB895F4B-C0D1-4B71-93BF-1EA8BC80EA8BQ33704379-E5E8E17A-9F16-4414-9D58-1E609816FBD8Q33704463-55BDE27B-B1A2-4B2E-9697-B58735107485Q33760804-E790DC60-2EF1-4E75-AD38-BAE730AC3905Q34051790-94692DCB-CB7B-41F8-B9D3-C51A53ADC63EQ34078191-F59B2669-A8CD-4AB0-9E62-0B9E517461ADQ34180436-4677BAE6-FB13-445F-8AE6-672FD2AE25FDQ34306144-F6DECD01-6090-4CE3-B86A-6B29E6E96670Q34535601-1C167AFB-DE0E-4C4C-8690-A3518668A343Q34594985-88970E0A-D909-4E37-8071-84CDC8D1B256Q34914187-67D3BD59-E780-4B97-9C33-46354BBED30FQ35000636-4DF1B996-CDF8-497E-9310-1C3B8E0B7723Q35016225-6CDA2701-581A-4D60-B13E-9244826B82C3Q35037251-94E500BC-FABE-454A-89E9-B375C8008BA8Q35042925-C6ADCCB0-E6B3-4877-92D8-827B44E16875Q35125252-840772B5-56A7-4912-B32F-C0A0F5602398Q35131272-B2B16427-64CF-4679-85DF-54ACF10F43DBQ35141499-488B4335-A37F-46DF-9542-0590E77119D2Q35151263-F4EF1C74-243A-43B3-A475-BF201AF21328Q35169098-7F7B297B-374C-4CCF-B9F4-5CD0A0BEF31FQ35252217-9AD8FF99-32BA-4BEF-A028-7B8F1394A1F6Q35650841-0D9C72EC-26E5-421F-A742-2FD45065E87EQ35660934-B92B427C-91CD-4052-BE42-CD8CCC8B5F00Q35670459-02AF3E56-D6E3-4572-ADA2-0E8FB87D5E00Q35726950-40A684B1-D1CC-46CF-AE9A-55AFF747AEB5Q36021686-8700EE80-423A-4247-8AE4-B74CAF565970Q36119176-D8A34AFC-6EB5-4245-B751-4DD93BF20F3CQ36327268-0B2AB9BB-FC70-4A1D-921D-9DCFEF3F6CB6Q36475108-90BE8D20-E22E-4ADA-B03E-DE8873B6C3CCQ36550616-F4E2371F-211A-426C-98B2-3B1D90E0F2ECQ36774229-CCFCB20B-F21D-470D-B3C9-E87BFBF59D76Q36908141-05CE82E0-9E77-4D2F-A3F7-747DEA7E46A8Q36966166-DE06661C-E4BE-4A92-A87A-38A4F9698EF2
P2860
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glucose metabolism of breast c ...... histochemical tissue analysis.
@ast
Glucose metabolism of breast c ...... histochemical tissue analysis.
@en
type
label
Glucose metabolism of breast c ...... histochemical tissue analysis.
@ast
Glucose metabolism of breast c ...... histochemical tissue analysis.
@en
prefLabel
Glucose metabolism of breast c ...... histochemical tissue analysis.
@ast
Glucose metabolism of breast c ...... histochemical tissue analysis.
@en
P2093
P1476
Glucose metabolism of breast c ...... ohistochemical tissue analysis
@en
P2093
Nathrath W
Schelling M
Schwaiger M
P407
P577
2001-01-01T00:00:00Z